Skip to content

Effects of preemptive analgesia with bromelain on postoperative reactions after mandibular third molar extraction: a split-mouth randomized trial

Effects of preemptive analgesia with bromelain on postoperative reactions after mandibular third molar extraction: a randomized trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107642
Enrollment
Unknown
Registered
2025-08-15
Start date
2024-10-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of preemptive analgesia with bromelain on postoperative pain after mandibular third molar extraction: a randomized controlled trial

Interventions

Group bromelain:Preemptive analgesia with bromelain orally
Group placebo:Pre-treatment with oral placebo

Sponsors

Quanzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Adult individuals aged 18 to 35 years, of any gender and ethnicity; 2. Good overall health (classified as ASA I and II by the American Society of Anesthesiologists) ; 3. No extraction contraindications; non-menstruating and non-lactating females; 4. Having both lower third molars, right and left, partially or fully impacted, with similar positioning and root formation, showing healthiness and indication for extraction; 5. Having no allergies to the pharmacological substances used in the study or their components and not to be taking other medications known to interact with bromelain; 6. Informed consent was obtained from all participants.

Exclusion criteria

Exclusion criteria: 1. Presence of pathological lesions associated with lower third molars; 2. Acute pericoronitis; 3. Recent history of chemotherapy and/or radiotherapy in the head and neck region, smoking, pregnancy, or lactation; 4. Classified as ASA III and IV by the American Society of Anesthesiologists; 5. Presence of renal or hepatic insufficiency; 6. Having allergies to the pharmacological substances used in the study or their components and be taking other medications known to interact with bromelain; 7. Surgery duration exceeding 40 min, difference in operative times exceeding 10 min; 8. Development of postoperative infection; 9. Failure to attend scheduled postoperative follow-up appointments, voluntary withdrawal during the research.

Design outcomes

Primary

MeasureTime frame
Postoperative pain ;

Secondary

MeasureTime frame
Oxygen saturation;Blood pressure;Heart rate;BMI;Facial swelling;Maximal interincisal opening;The use of additional analgesic medication;

Countries

China

Contacts

Public ContactHu Mingying

Quanzhou Medical College

947950125@qq.com+86 152 0507 8864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026